Unknown

Dataset Information

0

Chemoenzymatic Synthesis of Selegiline: An Imine Reductase-Catalyzed Approach.


ABSTRACT: (R)-Homobenzylic amines are key structural motifs present in (R)-selegiline, a drug indicated for the treatment of early-stage Parkinson's disease. Herein, we report a new short chemoenzymatic approach (in 2 steps) towards the synthesis of (R)-selegiline via stereoselective biocatalytic reductive amination as the key step. The imine reductase IR36-M5 mutant showed high conversion (97%) and stereoselectivity (97%) toward the phenylacetone and propargyl amine substrates, offering valuable biocatalysts for synthesizing alkylated homobenzylic amines.

SUBMITTER: Hu Y 

PROVIDER: S-EPMC10974447 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chemoenzymatic Synthesis of Selegiline: An Imine Reductase-Catalyzed Approach.

Hu Yuliang Y   Bao Jinping J   Tang Dongyu D   Gao Shushan S   Wang Fei F   Ding Zhongtao Z   Cui Chengsen C  

Molecules (Basel, Switzerland) 20240316 6


(<i>R</i>)-Homobenzylic amines are key structural motifs present in (<i>R</i>)-selegiline, a drug indicated for the treatment of early-stage Parkinson's disease. Herein, we report a new short chemoenzymatic approach (in 2 steps) towards the synthesis of (<i>R</i>)-selegiline via stereoselective biocatalytic reductive amination as the key step. The imine reductase IR36-M5 mutant showed high conversion (97%) and stereoselectivity (97%) toward the phenylacetone and propargyl amine substrates, offer  ...[more]

Similar Datasets

| S-EPMC8048798 | biostudies-literature
| S-EPMC6017073 | biostudies-literature
| S-EPMC3439149 | biostudies-literature
| S-EPMC10132124 | biostudies-literature
| S-EPMC4425689 | biostudies-literature
| S-EPMC8348920 | biostudies-literature
| S-EPMC11459430 | biostudies-literature
| S-EPMC10407936 | biostudies-literature
| S-EPMC8890093 | biostudies-literature
| S-EPMC4266379 | biostudies-literature